- Leveljump Healthcare Corp. (JUMP) has released its financial and operational results for the second quarter of 2021
- Canadian Teleradiology Services (CTS), Leveljump’s operating subsidiary, brought in over $1.6 million in revenue for the second quarter
- Compared to the first quarter, revenues were up by five per cent
- Leveljump Healthcare Corp. provides radiology solutions for hospitals, emergency rooms and private clinics
- Leveljump Healthcare Corp. (JUMP) is steady, trading at $0.225 per share
Leveljump Healthcare Corp. (JUMP) has released its financial and operational results for the second quarter of 2021.
Canadian Teleradiology Services (CTS), Leveljump’s operating subsidiary, brought in over $1.6 million in revenue for the second quarter and over $3.1 million for the first half of 2021.
Compared to the first quarter, revenues were up by five per cent and continued to increase despite COVID-19 lockdowns that continued to limit hospital activity.
CTS recorded a net operating profit of $114,000 in the second quarter and $201,216 for the first half of the year.
The company also recorded a negative adjusted EBITDA of $323,000 for the second quarter.
“Our negative EBITDA is primarily due to administrative costs for the parent company,” said CFO Rob Landau. “With the revenue stream from future acquisitions and the growth of CTS, profits from the operating businesses will overshadow the costs of maintaining the public company.”
Mitch Geisler, CEO of Leveljump, also commented on the results.
“We continue to increase our gross margins, one of our main financial goals for this fiscal year, while also decreasing operating expenses,” he remarked.
“The company continues to have a strong cash position with almost no debt,” he added, “providing us flexibility to grow in a variety of ways.”
A Canadian leader in B2B telehealth solutions, Leveljump Healthcare Corp. provides radiology solutions for hospitals, emergency rooms and private clinics.
The company provides telehealth services that are designed to provide doctor-to-doctor collaboration and diagnosis.
Leveljump Healthcare Corp. (JUMP) is steady, trading at $0.225 per share as of 3:45 pm ET.
